In December Walgreen’s announced a 40% stake in Sinopharm Holding Guoda Drugstores in China, expanding the company’s global reach. And the pharma retailer is getting into the data game, having spent over $500 million to-date on updating pharmacy management and data collection system and turning its 88.6 million user “Balance Rewards” program into a customer insight tool. Despite these expansion efforts and stronger than expected Q2 earnings, shareholders have watched the pharma retailer’s share price drop 22% since January, largely due to Amazon’s plan to sell prescription drugs to doctors and hospitals.
Looking for leads, investment insights, or competitive intelligence?
News about Walgreens Boots Alliance
Kaleo's allergy shot Auvi-Q will reportedly be free for those with commercial insurance.
Theranos defaulted on a Fortress loan.
Bold acquisitions and global expansion lifted Amerisource's ranking to number 12 on Fortune 500
Check your salads and wraps purchased from Trader Joe's, Walgreens, and Kroger.
Must-read business news, delivered every morning.